CALO', Girolamo
 Distribuzione geografica
Continente #
NA - Nord America 22.306
EU - Europa 4.716
AS - Asia 3.319
SA - Sud America 28
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 2
Totale 30.396
Nazione #
US - Stati Uniti d'America 22.259
CN - Cina 1.878
UA - Ucraina 1.380
DE - Germania 917
TR - Turchia 867
IT - Italia 814
GB - Regno Unito 646
SG - Singapore 405
SE - Svezia 320
FI - Finlandia 313
PL - Polonia 87
BE - Belgio 63
FR - Francia 52
RU - Federazione Russa 52
VN - Vietnam 49
CA - Canada 46
ID - Indonesia 34
CZ - Repubblica Ceca 27
IN - India 23
IR - Iran 16
HK - Hong Kong 14
BR - Brasile 13
CL - Cile 11
JP - Giappone 11
NL - Olanda 9
AU - Australia 7
NZ - Nuova Zelanda 7
A2 - ???statistics.table.value.countryCode.A2??? 6
KR - Corea 6
AT - Austria 5
EU - Europa 5
DK - Danimarca 3
GR - Grecia 3
HR - Croazia 3
IE - Irlanda 3
LU - Lussemburgo 3
RO - Romania 3
AR - Argentina 2
BG - Bulgaria 2
CH - Svizzera 2
IQ - Iraq 2
NO - Norvegia 2
YE - Yemen 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
BS - Bahamas 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MC - Monaco 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 30.396
Città #
Fairfield 3.307
Woodbridge 2.890
Houston 1.957
Ashburn 1.614
Jacksonville 1.591
Ann Arbor 1.518
Chandler 1.392
Seattle 1.339
Wilmington 1.180
Cambridge 1.156
Izmir 546
Nanjing 455
Princeton 355
Beijing 350
Ferrara 294
San Diego 280
Boardman 263
Singapore 241
New York 196
Shanghai 191
Milan 189
Nanchang 137
Shenyang 129
Dearborn 127
Falls Church 92
Warsaw 82
Hebei 81
San Mateo 81
Norwalk 78
Jiaxing 75
Bremen 74
Tianjin 74
Changsha 67
Redwood City 64
Mountain View 63
Brussels 61
Jinan 56
Addison 48
Auburn Hills 48
Munich 46
Dong Ket 45
London 43
Los Angeles 43
Kunming 42
Washington 42
Zhengzhou 41
Philadelphia 38
Jakarta 34
Mcallen 30
Guangzhou 29
Helsinki 29
Montréal 29
Tappahannock 28
Des Moines 27
Orange 27
Indiana 26
Ningbo 26
Bologna 23
Fuzhou 20
Verona 20
Brno 18
Lanzhou 18
Redmond 18
Leawood 17
Augusta 16
Hangzhou 14
Padova 14
Hounslow 12
Düsseldorf 10
Taizhou 10
Toronto 10
Ardabil 9
Bari 8
Changchun 8
Florence 7
Prescot 7
Walnut 7
Ferrara di Monte Baldo 6
Hefei 6
Hong Kong 6
Islington 6
Kilburn 6
Olomouc 6
San Francisco 6
Amsterdam 5
Chiswick 5
Haikou 5
La Canada Flintridge 5
Monmouth Junction 5
Mumbai 5
Yellow Springs 5
Boston 4
Central District 4
Chicago 4
Colleferro 4
Edinburgh 4
Hanoi 4
Jena 4
Messina 4
Moscow 4
Totale 23.745
Nome #
Chimeric G proteins in fluorimetric calcium assays: Experience with opioid receptors 238
null 205
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 196
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 164
Structural Bacterial Molecules as Potential Candidates for an Evolution of the Classical Concept of Probiotics 160
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ. 159
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 159
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 157
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 144
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 141
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 141
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 140
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 137
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 137
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 134
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 134
Emergency admissions of opioid drug-abusers for overdose. A chronobiological study of enhanced risk 133
A new selective antagonist of the nociceptin receptor 133
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 132
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 131
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 131
Pharmacological characterization of nociceptin receptor: an in vitro study 131
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 130
Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task. 129
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 129
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 129
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 129
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 129
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 128
In vitro pharmacological characterisation of a novel cyclic nociceptin/orphanin FQ analogue c[Cys(7,10)]N/OFQ(1-13)NH2 127
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 127
A new ligand for the urotensin II receptor 126
Ring size in cyclic endomorphin-2 analogs modulates receptor binding affinity and selectivity 126
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 125
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 125
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 124
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems 124
Modulation of the NOP receptor signaling affects resilience to acute stress 124
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 124
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 123
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 123
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 122
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 122
Cardiovascular effects of nociceptin in unanesthetized mice 120
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease 120
Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction 120
Effects of vasoactive agents in healthy and diseased human saphenous veins 120
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 120
AMPA receptor activation regulates the glutamate metabotropic receptor stimulated phosphatidylinositol turnover in human cerebral cortex slices 120
Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs. 119
Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness 119
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 119
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 118
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 117
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 117
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 116
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 116
Electrocardiographic alterations as a result of acute intoxication with fluvoxamine and pipamperone 116
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 115
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 115
[Nphe(1)]N/OFQ-(1-13)-NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices 114
Effects of neuropeptide S on seizures and oxidative damage induced by pentylenetetrazole in mice. 114
Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist 113
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 113
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 113
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 113
Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide s receptor activity 113
Actual concept of "probiotics": is it more functional to science or business? 112
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 112
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 112
Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese, hamster ovary cells expressing human nociceptin/orphanin FQ receptors 111
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 111
Role of nociceptin/orphanin FQ receptors in the decrease of mucosal mast cells caused by acute stress in the rat colon. 111
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration 111
null 110
Pharmacological characterization of tachykinin tetrabranched derivatives 110
Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells 109
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 108
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 108
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 108
Nociceptin/orphanin FQ inhibits ischaemia-induced glutamate efflux from rat cerebrocortical slices 107
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 107
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. 107
Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies. 107
Inhibitory effect of NMDA receptor activation on quisqualate-stimulated phosphatidylinositol turnover in the human cerebral cortex 107
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 107
Desensitisation of native and recombinant human urotensin-II receptors. 107
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 107
Sudden death from pulmonary thromboembolism: chronobiological aspects 106
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 106
Structure-activity study at positions 3 and 4 of human neuropeptide S. 106
Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux 105
Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands 105
B1 and B2 kinin receptors in various species 105
null 105
Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test 104
Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain 104
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 104
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 104
Blockade of adenosine A2A receptor counteracts neuropeptide-S-induced hyperlocomotion in mice. 104
Totale 12.329
Categoria #
all - tutte 127.384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.364
Totale 129.748


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.467 1.069 269 255 1.078 558 872 748 783 660 653 331 191
2020/20214.830 378 445 264 570 307 489 167 567 154 634 577 278
2021/20223.644 144 369 312 217 203 190 217 236 156 302 313 985
2022/20233.455 379 160 114 414 572 485 177 315 470 21 196 152
2023/20241.781 196 229 88 50 99 310 74 142 35 30 53 475
2024/2025142 142 0 0 0 0 0 0 0 0 0 0 0
Totale 30.861